Skip to content

Cognitive rehabilitation therapy in patients with somatic symptom and related disorders.

Cognitive rehabilitation therapy in patients with somatic symptom and related disorders. - Cognitive rehabilitation therapy in somatic symptom and related disorders.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON50112
Enrollment
40
Registered
2021-03-03
Start date
2021-10-04
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

somatic symptom and related disorder

Interventions

Cognitive rehbailitation therapy (CRT) aims to learn a compensatory strategy to overcome cognitive symptoms in a broad range of cognitive domains. For instance, the protocol for impaired mental spee

Sponsors

GGZ instellingen / Psychiatrische Ziekenhuizen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients with SSRD, >= 18 years, cognitive symptoms.

Exclusion criteria

Exclusion criteria: Exclusion criteria: direct risk of suicide, dementia, usage of illicit drugs within the past 6 months, consumption of more than 21 units of alcohol per week, illiteracy, insufficient knowledge of Dutch language or short-term risk of psychoses, and refusal to informed consent .

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study is subjective cognitive functioning as measured by the Cognitive Faillure Questionnaire (CFQ) (Broadbent,Cooper, FitzGerald & Parkes, 1982). The CFQ is a self-report questionnaire related to everyday cognitive failure/misstakes related to cognitive functioning. The questionnaire consists of 25 items which are measured using a 5-point scale (0 = never, 4=always). The CFQ has good psychometric properties, include test-retest reliability (Ponds, van Boxtel & Jolles, 2006) and reliability (Bridger, Johnsen& Brasher, 2013). Higher scores are indicative for more subjective congitive symptoms. The CFQ-scores are measured before, during (6 weeks) and after treamtnt to evaluate the course of cognitive functioning during therapy.

Secondary

MeasureTime frame
Neuropsychological assesment (NPA) is conducted twice. Firstly, NPA is conducted to provide a framework for the therapy sessions. The second NPA is conducted to evaluate objective cognitive functioning after therapy. This NPA takes approximately 30 minutes and is considered an (minimal) extra effort for patients. NPA is used to assess the different cognitive domains (e.g., memory, attention, executive functioning). Scores will be transformed into classificantion 'no cognitive disorders' (equal to or larger that 20th percentile), 'impaired cognitive functioning' (between 2nd and 20th percentile), and 'cognitive disorder' (smaller than 2nd percentile) based upon the criteria from Lezak, Howiesan, & Loring (2012). The following tests will be conducted: the digit span and symbol substitution from the Wechsler Adult Intelligence Scale (WAIS-IV-NL; Wechsler, 2012) is used to assess working memory and information processing speed, respectively. The Tower test of the DKEFS (Delis et al, 2001) is used to assess planning (Executive functioning), and the rey auditory verbal learning test (15WT; Kalverboer & Deelman, 1986) is used to assess verbal memory processes. The rey osterrieth complex figure test is used to assess visual memory (Osterrieth, 1944) and the d2 is used to assess attention (Brickenkamp, 2002). The psychometric properties of these tests are sufficient and can be found in the manuals (Brickenkamp, 2002;'Delis et al., 2001; Kalverboer & Deelman, 1986; Wechsler, 2012). Note: to control for possible learning effect, during the second NPA the b-version of the RAVLT will be conducted. The learning effect of the other tests are considered minimal

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)